Product Images Sacubitril And Valsartan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Sacubitril And Valsartan NDC 71610-939 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 71610 0939 89
Aphena - Aphena
figure-1 - sacubitril valsartan figure 1
This text presents a list of coadministered drugs along with their geometric mean ratio and 90% CI. The drugs listed include Furosemide, Warfarin, Digoxin, Carvedilol, Levonorgestrel, Ethinyl estradiol, Amlodipine, HerTZ, Metformin, Atorvastatin, and Sildenafil, with their respective values indicated. The text also mentions a change relative to reference for each drug.*
figure-2 - sacubitril valsartan figure 2
sacubitril-valsartan-figure-3.jpg - sacubitril valsartan figure 3
This is a comparison of the time to first occurrence of cardiovascular (CV) death or heart failure hospitalizations between two treatments, Sacubitril and Valsartan versus Enalapril, conducted in the PARADIGM-HF study. The data shows a statistically significant difference (p<0.0001) favoring Sacubitril and Valsartan in reducing the risk of CV death or heart failure hospitalizations. Additionally, time to occurrence of CV death and heart failure hospitalizations is illustrated along with cumulative failure rates. This information provides valuable insights into the efficacy of each treatment in managing heart failure patients.*
structure - sacubitril valsartan structure
sacubitril-valsartanl-figure-4.jpg - sacubitril valsartanl figure 4
The text provided contains data related to a clinical trial, including information about different subgroups based on age, gender, weight, race, region, medical history, and other categories. It also lists the percentages and numbers of individuals within each subgroup who were treated with Sacubitril and Valsartan or Enalapril. Additionally, the text mentions hazard ratios for the comparison between Sacubitril and Valsartan and Enalapril. The data seems to be part of a study evaluating the effectiveness of these medications for heart failure.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
